In addition to targeting inhibitory cytokines in TIME, CAR-T cells could be equipped with ability to secrete pro-inflammatory cytokines such as IL-12 and IL18 to remodel suppressive TIME and boost anti-tumor effects. The gene discussed is IL18; the disease is neoplasm.